3月4日 - ** Hoth Therapeutics HOTH.O股价盘前上涨4.33%至1.04美元
** 该公司称正在使用OpenAI工具帮助开发治疗由KIT基因缺陷引起的罕见癌症的药物，而该缺陷可推动肿瘤生长
** 该公司表示，其实验性药物 HT-KIT 的早期测试在实验室和动物实验中大幅降低了 KIT 基因的水平，而且没有出现严重的副作用。
** 公司称，HOTH 的 HT-KIT 还能在短短一周多内使动物体内的肿瘤缩小
** 该公司准备申请美国批准，开始人体试验；该药物具有孤儿地位
** 2025 年股价上涨约 32%
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.